Drug intelligence / Profile preview

Jack Herer

Development stage
Unknown
Lead developer
Sensi Seeds
Modality
Small Molecules
Administration
Inhalation, Oral
01

Overview

Jack Herer is a sativa-dominant hybrid medical cannabis strain developed by Sensi Seeds in the Netherlands during the mid-1990s. It is a genetic cross between a Haze hybrid, Northern Lights #5, and Shiva Skunk. The strain is pharmacologically active as an agonist at the cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2), primarily mediated by its delta-9-tetrahydrocannabinol (THC) content, which typically ranges from 15% to 24%. It also contains low levels of cannabidiol (CBD) and a specific terpene profile consisting of terpinolene, caryophyllene, and pinene. Jack Herer is recognized for producing balanced cerebral and physical effects, often described as blissful and creative, and has been distributed as a medical-grade product through Dutch pharmacies. Clinical research has explored its use in various settings, including its potential to improve oxygenation in patients following heart surgery.

Brand names
Jack Herer
Other names
Jack Herer strainJH strain
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Jack Herer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jack Herer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call